Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Moodys
Merck
AstraZeneca
McKinsey

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Claims for Patent: 8,492,416


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,492,416
Title:2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, ##STR00001## wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
Inventor(s): Kenda; Beno t (Emines, BE), Pasau; Patrick (Chastre, BE), Lallemand; Benedicte (Namur, BE)
Assignee: UCB Pharma, S.A. (Brussels, BE)
Application Number:13/222,477
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,492,416
Patent Claims: 1. A method for treatment of epilepsy, seizure disorders and convulsions comprising administering to a mammal in need thereof a therapeutically effective amount of (2S)-2-[(4R)-2-oxo-4-propylpyrrolidinyl]butanamide.

2. The method for treatment according to claim 1, wherein epilepsy is treated.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
McKesson
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.